QA: Seelos Therapeutics INC in us_pharma/2012

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001017491_2013_Seelos_Therapeutics_INC.pdf

Logs

warning The stock price does not exist industry.us_generic {}

Graph

Absolute values for 0001017491, Seelos Therapeutics INC

  xvar xval
0 AssetsCurrent 20,895,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 601,000
3 remainder_Assets 2,383,000
4 LiabilitiesCurrent 10,766,000
5 LiabilitiesNoncurrent 196,000
6 remainder_Liabilities 6,296,000
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 15,377,000
9 ResearchAndDevelopmentExpense 5,375,000
10 remainder_Expenses 13,074,000
11 remainder_Revenues 8,416,000
12 remainder_NetIncome -6,361,000
13 remainder_ComprehensiveNetIncome 641,000
  yvar yval
0 Assets 23,879,000
1 Liabilities 17,258,000
2 Expenses 33,826,000
3 Revenues 8,416,000
4 StockholdersEquity 6,621,000
5 NetIncome -31,771,000
6 ComprehensiveNetIncome -31,450,500
7 BaseVar 45,190,500
8 EconomicCapitalRatiobeforeLimitedLiability -0.827
9 EconomicCapitalRatio 1.34

Edgar->Model Mapping

Feature Distribution

Change over Time